(Q46664706)

24 December 2017

editorial

0 references

title

EGF receptor activation by heterologous mechanisms (English)

1 reference

24 December 2017

author name string

Kermit L Carraway

series ordinal

1

1 reference

24 December 2017

Colleen Sweeney

series ordinal

2

1 reference

24 December 2017

publication date

1 June 2002

1 reference

24 December 2017

published in

Cancer Cell

1 reference

24 December 2017

volume

1

1 reference

24 December 2017

page(s)

405-406

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

The urokinase-type plasminogen activator system in cancer metastasis: a review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Muc4/sialomucin complex in the mammary gland and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Urokinase receptor: a molecular organizer in cellular communication.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

Novel mechanisms of RTK signal generation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900076-4

7 January 2021

10.1016/S1535-6108(02)00076-4

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

12124166

1 reference

24 December 2017